These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16459633)

  • 101. Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases.
    Dagenborg VJ; Marshall SE; Yaqub S; Grzyb K; Boye K; Lund-Iversen M; Høye E; Berstad AE; Fretland ÅA; Edwin B; Ree AH; Flatmark K
    Cancer Biol Ther; 2020 May; 21(5):432-440. PubMed ID: 32098573
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy.
    Araujo RLC; Milani JM; Armentano DP; Moreira RB; Pinto GSF; de Castro LA; Lucchesi FR
    J Surg Oncol; 2020 Apr; 121(5):848-856. PubMed ID: 31773747
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Prediction of the efficacy of first-line oxaliplatin-based chemotherapy for unresectable liver metastases of colorectal cancer by Köhne's index].
    Okada N; Ishibashi K; Ohsawa T; Sobajima J; Kuwabara K; Amano K; Hatano S; Suzuki O; Kumamoto K; Kumagai Y; Baba H; Haga N; Tsuji Y; Ishida H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2195-7. PubMed ID: 23268021
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Resection of colorectal liver metastases: current perspectives.
    McLoughlin JM; Jensen EH; Malafa M
    Cancer Control; 2006 Jan; 13(1):32-41. PubMed ID: 16508624
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases.
    Rubbia-Brandt L; Mentha G; Terris B
    J Am Coll Surg; 2006 Jan; 202(1):199-200. PubMed ID: 16377516
    [No Abstract]   [Full Text] [Related]  

  • 106. [Significance of Neoadjuvant Chemotherapy before Colorectomy and Hepatectomy].
    Kuwata D; Miura T; Sakamoto Y; Morohashi H; Ichinohe D; Fujita H; Yamazaki K; Hakamada K
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1541-1543. PubMed ID: 35046249
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months.
    Nishino H; Hatano E; Okuno M; Toda R; Seo S; Taura K; Horimatsu T; Kanai M; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    Am Surg; 2019 Feb; 85(2):e111-e114. PubMed ID: 30819321
    [No Abstract]   [Full Text] [Related]  

  • 108. Histological tumor response to neoadjuvant chemotherapy correlates to Immunoscore in colorectal cancer liver metastases patients.
    Zhang C; Wang X; Han J; Zhang R; Chen Z; Li Y; Ma X; Zhang G; Fan J; Chen J
    J Surg Oncol; 2021 Dec; 124(8):1431-1441. PubMed ID: 34406653
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?
    Ayez N; Lalmahomed ZS; van der Pool AE; Vergouwe Y; van Montfort K; de Jonge J; Eggermont AM; Ijzermans JN; Verhoef C
    Ann Surg Oncol; 2011 Oct; 18(10):2757-63. PubMed ID: 21638093
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Thinking Too Fast About Chemotherapy for Resectable Colorectal Cancer Liver Metastases?
    Pereira AAL; Dos Santos Fernandes G
    Clin Colorectal Cancer; 2022 Sep; 21(3):e187-e188. PubMed ID: 35680525
    [No Abstract]   [Full Text] [Related]  

  • 111. Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons.
    Mohammad WM; Martel G; Mimeault R; Fairfull-Smith RJ; Auer RC; Balaa FK
    HPB (Oxford); 2012 May; 14(5):291-7. PubMed ID: 22487066
    [TBL] [Abstract][Full Text] [Related]  

  • 112. [China Guideline for Diagnosis and Comprehensive Treatment of Colorectal Liver Metastases (Version 2018)].
    Xu J; Ren L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):601-626. PubMed ID: 29968235
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
    Narita M; Oussoultzoglou E; Jaeck D
    Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S310. PubMed ID: 21845500
    [No Abstract]   [Full Text] [Related]  

  • 114. [Treatment of colorectal and non-colorectal liver metastases: rationale for neoadjuvant therapeutic concepts].
    Gül-Klein S; Schmuck R; Modest DP; Pratschke J
    Chirurg; 2020 May; 91(5):396-404. PubMed ID: 32291472
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Chemotherapy in patients with a solitary colorectal liver metastasis - A nationwide propensity score matched study.
    Frühling P; Urdzik J; Isaksson B
    Eur J Surg Oncol; 2022 Oct; 48(10):2188-2194. PubMed ID: 35672233
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.
    Bruun J; Kryeziu K; Eide PW; Moosavi SH; Eilertsen IA; Langerud J; Røsok B; Totland MZ; Brunsell TH; Pellinen T; Saarela J; Bergsland CH; Palmer HG; Brudvik KW; Guren T; Dienstmann R; Guren MG; Nesbakken A; Bjørnbeth BA; Sveen A; Lothe RA
    Clin Cancer Res; 2020 Aug; 26(15):4107-4119. PubMed ID: 32299813
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Immune checkpoints and liver resection after neoadjuvant chemotherapy including bevacizumab in patients with microsatellite-stable colorectal liver metastases.
    Stift J; Graf A; Neudert B; Herac M; Woeran K; Tamandl D; Laengle J; Schwarz C; Wrba F; Kaczirek K; Stremitzer S
    HPB (Oxford); 2022 Jan; 24(1):40-46. PubMed ID: 34158230
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Management of disappearing colorectal hepatic metastases.
    Carpenter S; Fong Y
    Adv Surg; 2010; 44():269-79. PubMed ID: 20919526
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Complete remission of multiple liver metastases with only partial response of the primary rectal cancer after neoadjuvant chemotherapy.
    Miura S; Ito K; Takemura N; Mihara F; Kiyomatsu T; Kokudo N
    Surg Case Rep; 2020 Feb; 6(1):46. PubMed ID: 32107670
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Limited influences of chemotherapy on healthy and metastatic liver parenchyma.
    Van Damme N; Demetter P; De Bock W; Rottiers M; Praet M; de Hemptinne B; Peeters M
    World J Gastroenterol; 2005 Sep; 11(34):5322-6. PubMed ID: 16149139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.